Deep brain stimulation for Parkinson's disease: Patient selection and evaluation

Critical to the successful application of deep brain stimulation for the treatment Parkinson's disease is the proper selection of patients who will reliably benefit from this procedure and the successful evaluation of the responses obtained. This review will discuss the various factors influencing patient selection and summarize the recommended approach to patient assessment by using the Core Assessment Program for Surgical Interventions and Transplantation in Parkinson's Disease (CAPSIT‐PD). © 2002 Movement Disorder Society

[1]  A. Lang,et al.  Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease , 1998, Neurology.

[2]  A L Benabid,et al.  Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. , 1998, Brain : a journal of neurology.

[3]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .

[4]  K. Meador,et al.  The evocative nature of emotional content for sensory and motor systems , 2001, Neurology.

[5]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[6]  A. Benabid,et al.  Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson’s disease , 2000, Neurology.

[7]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[8]  Y. Agid,et al.  Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD , 2000, Neurology.

[9]  F. Windels,et al.  Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat , 2000, The European journal of neuroscience.

[10]  V Sturm,et al.  Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD , 2001, Neurology.

[11]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[12]  J. Saint-Cyr,et al.  Neuropsychologic assessment of patients for movement disorder surgery , 2000, Movement disorders : official journal of the Movement Disorder Society.

[13]  M. Hariz,et al.  Hardware failure in parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency , 2001, Movement disorders : official journal of the Movement Disorder Society.

[14]  A. Benabid,et al.  Neuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease. , 1999, Journal of neural transmission. Supplementum.

[15]  P. Pollak,et al.  The core assessment program for intracerebral transplantation. , 1995, Movement disorders : official journal of the Movement Disorder Society.

[16]  M. Seiwald,et al.  Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic Parkinson's disease: one year follow-up , 1999, Journal of Neural Transmission.

[17]  K. Lyons,et al.  High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease , 1997, Neurology.

[18]  E. Moro,et al.  Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease , 1999, Neurology.

[19]  H. Widner,et al.  Clinical rating of dyskinesias in Parkinson's disease: Use and reliability of a new rating scale , 1999, Movement disorders : official journal of the Movement Disorder Society.

[20]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[21]  P. Remy,et al.  Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT‐PD) , 1999, Movement disorders : official journal of the Movement Disorder Society.

[22]  Bonifati,et al.  Association between early-onset Parkinson's disease and mutations in the parkin gene. , 2000, The New England journal of medicine.

[23]  Y Agid,et al.  Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. , 2000, Archives of neurology.

[24]  D. Brooks,et al.  Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.

[25]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[26]  J. Speelman,et al.  Quality of life in patients with Parkinson's disease: development of a questionnaire. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[27]  A. Benabid,et al.  Subthalamic Nucleus Lesion in Rats Prevents Dopaminergic Nigral Neuron Degeneration After Striatal 6‐OHDA Injection: Behavioural and Immunohistochemical Studies , 1996, The European journal of neuroscience.

[28]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[29]  N. P. Quinn,et al.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy , 1996, Neurology.

[30]  J. Obeso,et al.  Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. , 2000, Neurology.

[31]  M. Yamada,et al.  [Dementia rating scale]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.

[32]  D. Guehl,et al.  High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases. , 1997, Journal of neurosurgery.

[33]  K J Burchiel,et al.  Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. , 1999, Neurosurgery.

[34]  A. Antonini,et al.  Preoperative indicators of clinical outcome following stereotaxic pallidotomy , 1997, Neurology.

[35]  J. Obeso,et al.  Subthalamic nucleus‐mediated excitotoxicity in parkinson's disease: A target for neuroprotection , 1998, Annals of neurology.

[36]  M. V. Van Woert,et al.  Start hesitation--a side effect of long-term levodopa therapy. , 1973, The New England journal of medicine.

[37]  J. Molinuevo,et al.  Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. , 2000, Archives of neurology.

[38]  A. Benabid,et al.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.

[39]  V Sturm,et al.  Bilateral high‐frequency stimulation of the internal globus pallidus in advanced Parkinson's disease , 1998, Annals of neurology.

[40]  F. Durif,et al.  Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.